A new clinical trial gives more hope to patients and us another medicine in our arsenal, says diabetologist Dr Anoop Misra ...
Novo Nordisk is facing the prospect of intensifying competition in the promising Chinese market where drugmakers are ...
Taipei, Taiwan – Ozempic is big business in China. Last year, the Danish pharmaceutical giant Novo Nordisk doubled its sales ...
The FDA cited flaws in a company's study into the use of MDMA as a treatment for post-traumatic stress disorder. Separately, reports say some drugmakers will cap asthma inhaler costs at $35 a month; ...
While the UK stock market is rising, the Diageo share price is falling. Here, Edward Sheldon looks at what’s going on with ...
Edward Sheldon believes these three growth stocks could generate fantastic returns for his investment portfolio in the years ahead.
share price has more than quadrupled in the past five years. According to analytics firm Trilliant Health, in the last 3 ...
Providing GLP-1 drugs to 19.7 million Medicare beneficiaries with obesity would cost $268 billion a year, researchers ...
The drugs belong to a class of treatments known as GLP-1s, which help regulate blood sugar and cause the stomach to empty ...
In a letter to Bernie Sanders, Novo Nordisk said it only retains 60% of the list price of either Ozempic or Wegovy ...
Stomach paralysis, also know as gastroparesis, weakens the stomach muscles, leading to food sitting in the main digestive ...